Frelick Jeff Insider Trades

Insider Trading History

Track insider trading activity for Frelick Jeff. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $20.7k 16,668 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$25.8k 16,668 shares
$1.55
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $233k 16,668 shares
Last Trade
Jan 08, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$245k 16,668 shares
$14.70
$14.00
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $758k 54,110 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$19.2M 54,110 shares
$355.20
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $67.1k 54,110 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$52.5k 54,110 shares
$0.97
$1.24
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $31k 25,000 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.3k 25,000 shares
$3.61
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $350k 25,000 shares
Last Trade
Jan 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$705k 25,000 shares
$28.20
$14.00
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $241k 17,204 shares
Last Trade
Sep 11, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$459k 9,500 shares
$48.30
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $21.3k 17,204 shares
Last Trade
Sep 11, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$50.9k 9,500 shares
$5.36
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $108k 7,704 shares
Last Trade
Aug 31, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$182k 7,600 shares
$24.00
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $9.55k 7,704 shares
Last Trade
Aug 31, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$41.2k 7,600 shares
$5.42
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $1.96M 140,140 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.06k 37,750 shares
$0.24
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $174k 140,140 shares
Last Trade
Jan 25, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 37,750 shares
$41.92
$1.24
Bone Biologics
Bone Biologics BBLG
Chief Executive Officer
Holding Value $127k 102,389 shares
Last Trade
Jan 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.1M 50,000 shares
$422.82
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Executive Officer
Holding Value $1.43M 102,389 shares
Last Trade
Jan 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$0 50,000 shares
$0.00
$14.00
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Operating Officer
Holding Value $1.08M 77,377 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Operating Officer
Holding Value $95.9k 77,377 shares
Last Trade
Feb 16, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Operating Officer
Holding Value $18.6M 1,326,204 shares
Last Trade
May 27, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Operating Officer
Holding Value $1.64M 1,326,204 shares
Last Trade
May 27, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.24
Bone Biologics - Warrants (13/10/2026)
Bone Biologics - Warrants (13/10/2026) BBLGW
Chief Operating Officer
Holding Value $230k 16,463 shares
Last Trade
Mar 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$14.00
Bone Biologics
Bone Biologics BBLG
Chief Operating Officer
Holding Value $20.4k 16,463 shares
Last Trade
Mar 25, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$1.24

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up